Send us a text

Join us in this episode where we look at the treatment landscape in ovarian cancer.
We talk to Dr Shibani Nicum and Dr Rebecca Bowen who both specialise in the treatment of ovarian cancer.
They both lead the UK Gynae Trials Group (GTG) group and are involved in running the excellent UK Gynae-oncology Meeting (UKGOM).
We look at the use of PARPi, Bevacizumab (Avastin) and new targets in ovarian cancer.

This is a rapidly changing environment and this is an excellent overview by Shibani and Rebecca.

We hope you enjoy.

John & Mike

ps- With exclusive update on the date of next years UKGOM meeting